News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. and Iran paused direct talks in Islamabad after a 14-hour session with key disputes unresolved.
  • Technical experts will continue document exchanges while political disputes remain unresolved.
  • Strait of Hormuz saw a naval confrontation and Iranian radio warning as U.S. warships transited, keeping oil-route risk elevated.
  • Islamabad enforced tight security and near-empty streets as senior U.S. and Iranian delegations met.
  • European consumers' willingness to buy Chinese cars rose to 55%, pressuring incumbent automakers.
  • Costa Rica received 25 migrants deported from the U.S. under a weekly transfer pact, with international aid offered.

Latest Articles

Anavex Life Sciences Provides Comprehensive Regulatory Update

Anavex Life Sciences Provides Comprehensive Regulatory Update

Anavex Life Sciences Corp. provides a regulatory update on its lead drug candidate blarcamesine, highlighting ongoing discussions with the European Medicines Agency (EMA) for early Alzheimer’s disease following the withdrawal of EU marketing authorization application. Additional data has been submitted to the U.S. FDA to explore pathways toward a N…

Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program

Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program

Alterity Therapeutics announced positive regulatory feedback from a Type C Meeting with the FDA regarding its planned Phase 3 clinical trial program for ATH434 targeting Multiple System Atrophy (MSA). The FDA has provided written support for clinical pharmacology and non-clinical development plans, marking a significant step toward initiating the P…

Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform

Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform

iRhythm Holdings, a US-based digital healthcare company, presented real-world data at ACC.26 demonstrating the high prevalence of actionable arrhythmias detected by its Zio® ambulatory ECG portfolio across diverse patient populations along the cardiovascular-kidney-metabolic continuum. The studies underscore the value of early, targeted cardiac mon…

Willis Lease Finance Corporation Amends Revolving Credit Facility

Willis Lease Finance Corporation Amends Revolving Credit Facility

Willis Lease Finance Corporation announced the amendment and extension of its revolving credit facility, increasing total commitments from $1 billion to $1.75 billion and extending the maturity to April 2031. The facility was oversubscribed by about $1 billion, demonstrating strong lender confidence in the company's platform. This expanded credit f…

Nano Labs Announces Second Half of 2025 Financial Results

Nano Labs Announces Second Half of 2025 Financial Results

Nano Labs Ltd announced its unaudited financial results for the second half of 2025, reporting an 18.1% increase in net revenues to RMB18.7 million (US$2.7 million) and a strong net income of RMB137.7 million (US$19.6 million), reversing the previous year's loss. The company benefited from a significant gain on the fair value of cryptocurrencies, s…

FactSet Accelerates Innovation in Banking with Launch of a New AI-Native Solution in Partnership with Finster AI

FactSet Accelerates Innovation in Banking with Launch of a New AI-Native Solution in Partnership with Finster AI

FactSet unveils FactSet AI for Banking, an AI-powered workflow automation platform developed with Finster AI. This unified solution streamlines deal processes, integrates multiple data sources, and offers extensive automation capabilities tailored for investment banking teams. The launch reflects FactSet's commitment to AI-driven innovation and inc…

Lotus For Me SUV Officially Launches: Redefining Performance and Versatility with X-Hybrid Technology

Lotus For Me SUV Officially Launches: Redefining Performance and Versatility with X-Hybrid Technology

Lotus Technology Inc. officially launched its For Me hyper SUV, the first mass-produced Lotus featuring its new X-Hybrid Architecture. The vehicle delivers 952 horsepower, a 0-100 km/h acceleration in 3.3 seconds, and maintains performance regardless of battery level. It boasts advanced lightweight engineering, superior handling, comprehensive safe…

Innventure Reports Fourth Quarter and Full Year 2025 Results

Innventure Reports Fourth Quarter and Full Year 2025 Results

Innventure, Inc. reported its financial results for Q4 and full year 2025, highlighting a significant commercial inflection with bookings exceeding $50 million in early 2026. The company’s operating subsidiaries are successfully raising independent capital, thereby reducing Innventure’s balance sheet reliance. Innventure cut consolidated G&A costs …

Scorpio Tankers Inc. Announces Vessel Sale Agreements

Scorpio Tankers Inc. Announces Vessel Sale Agreements

Scorpio Tankers Inc., a marine transportation company specializing in petroleum products, has entered into agreements to sell two 2015-built scrubber-fitted MR product tankers, STI Brooklyn and STI Black Hawk, for $35 million each. The sales are expected to close in the second quarter of 2026. The company also disclosed agreements to sell additiona…

Rezolve Ai Delivers 543% H2 Growth; Raises 2026 Revenue Guidance to $360M as Platform Achieves Global Infrastructure Scale

Rezolve Ai Delivers 543% H2 Growth; Raises 2026 Revenue Guidance to $360M as Platform Achieves Global Infrastructure Scale

Rezolve Ai, a leader in AI-powered retail infrastructure, delivered $46.8M revenue for 2025, significantly exceeding market expectations with an explosive second half growth of 543%. The company ended 2025 at a $232M Annual Recurring Revenue (ARR) run rate and raised its 2026 revenue guidance to $360M with an anticipated ARR exit of $500M. Strong f…

Sagtec Global (NASDAQ: SAGT) to Launch Sovereign AI Data Center Powered by NVIDIA GPU Architecture; Infrastructure Pivot to Support Millions of Daily F&B Retail Ordering, Retail and Fintech Transactions

Sagtec Global (NASDAQ: SAGT) to Launch Sovereign AI Data Center Powered by NVIDIA GPU Architecture; Infrastructure Pivot to Support Millions of Daily F&B Retail Ordering, Retail and Fintech Transactions

Sagtec Global Limited (NASDAQ: SAGT) is launching its proprietary Sovereign AI Data Center through its subsidiary CL Technologies (International) Sdn Bhd. This facility, powered by NVIDIA GPU architecture, is designed to support millions of daily transactions in food & beverage (F&B) retail ordering, retail operations, and fintech, marking a strate…

SiriusPoint announces changes to Board of Directors

SiriusPoint announces changes to Board of Directors

SiriusPoint Ltd., a specialty underwriter listed on the NYSE, has appointed Sabra Purtill to its Board of Directors while Franklin Montross IV and Peter Tan will step down in May 2026. The company highlights its focus on discipline, resilience, and long-term value as it evolves its governance and strategic direction.

Aprea Therapeutics Highlights Positive Emerging Clinical Activity for WEE1 Inhibitor, APR-1051, with a Confirmed Partial Response in the Ongoing Phase 1 ACESOT-1051 Trial

Aprea Therapeutics Highlights Positive Emerging Clinical Activity for WEE1 Inhibitor, APR-1051, with a Confirmed Partial Response in the Ongoing Phase 1 ACESOT-1051 Trial

Aprea Therapeutics announced a confirmed partial response in their ongoing Phase 1 ACESOT-1051 trial for APR-1051, a selective WEE1 kinase inhibitor targeting biomarker-defined cancers. The response was observed at the 220 mg dose in a patient with PPP2R1A-mutated endometrial cancer, with sustained tumor reduction and decreasing CA-125 levels. The …

Plains All American Pipeline and Plains GP Holdings Provide Updated Timing for Completion of Sale of NGL Business

Plains All American Pipeline and Plains GP Holdings Provide Updated Timing for Completion of Sale of NGL Business

Plains All American Pipeline, L.P. and Plains GP Holdings announced an updated expected closing date for the sale of their Canadian natural gas liquids (NGL) business to Keyera Corp, now anticipated in May 2026 following ongoing regulatory review. The transaction aims to reposition Plains as a pure play crude oil midstream company with integrated N…

Standard Lithium Reports Fourth Quarter and Full Year 2025 Results

Standard Lithium Reports Fourth Quarter and Full Year 2025 Results

Standard Lithium Ltd. announced strong fourth quarter and full year 2025 results highlighted by signing its first binding offtake agreement to supply 8,000 tonnes per year of battery-grade lithium carbonate to Trafigura over 10 years. The company received over $1 billion in project finance indications and progressed towards a final investment decis…

electroCore Expands Intellectual Property Portfolio

electroCore Expands Intellectual Property Portfolio

electroCore, Inc. announces the issuance of two new U.S. patents expanding its intellectual property portfolio covering non-invasive vagus nerve stimulation (nVNS) technology. These patents enhance protection of their core platforms and related wellness products, potentially extending patent coverage into the late 2030s and beyond, reinforcing elec…